Interview with Joachim Coenen: Big Data and AI in Animal Research
The COVID-19 pandemic reminded us of the devastating consequences that the transmission of pathogens from animals to humans can have. It’s not only the animals themselves that suffer from epidemics and diseases. According to the One Health approach, they need a good supply of medicines to protect their own health and that of humans.
2. Profile of Dr. Joachim Coenen
Dr. med. vet. Joachim Coenen is Senior Expert Animal Science and Welfare at the Merck Group (EMD in the USA and Canada) and works in SQ-A (Corporate Animal Affairs) at the Merck Group. Dr. Coenen graduated as a veterinarian and obtained his doctorate in biochemistry and endocrinology from the University of Giessen in Germany. He is a specialist veterinarian for experimental animal science and certified as a Diplomate of the American Board of Toxicology (DABT). In addition to his experience in animal science and animal welfare, he has more than 15 years of experience in non-clinical drug development, licensing and outsourcing and has worked in the German and US pharmaceutical industries. Among many other activities in national and international associations (EFPIA, vfa), he serves as Council Chair of the SET Foundation and is Chair of the Animal Welfare Working Group of Interpharma – the association of Switzerland’s research-based pharmaceutical industry, currently serving as Immediate Past Chair on the Board of Directors of AAALAC International and member of the Federal Commission for Animal Welfare at the German Federal Ministry of Food and Agriculture.